Lee Sung Woo, Yu Mi-Yeon, Baek Seon Ha, Ahn Shin-Young, Kim Sejoong, Na Ki Young, Chae Dong-Wan, Chin Ho Jun
Department of Immunology, Seoul National University Postgraduate School, Seoul, Korea.
Division of Nephrology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
PLoS One. 2016 Jan 22;11(1):e0147387. doi: 10.1371/journal.pone.0147387. eCollection 2016.
There has been little published information on risk factors for poor long-term outcome in adult biopsy-proven minimal change disease (MCD).
Data from sixty-three adult, biopsy-proven primary MCD patients treated at a tertiary university hospital between 2003 and 2013 were analyzed. Baseline clinical and pathologic factors were assessed for the associations with composite outcome of creatinine doubling, end stage renal disease, or all-cause mortality.
During a median (interquartile) 5.0 (2.8-5.0) years, the composite outcome occurred in 11.1% (7/63) of patients. The rate of glomerular immune deposits was 23.8% (15/63). Patients with glomerular immune deposits showed a significantly lower urine protein creatinine ratio than those without deposits (P = 0.033). The rate of non-responders was significantly higher in patients with glomerular immune deposits than in those without deposits (P = 0.033). In patients with deposits, 26.7% (4/15) developed the composite outcome, while only 6.3% (3/48) developed the composite outcome among those without deposits (P = 0.049). In multivariate Cox proportional hazards regression analysis, the presence of glomerular immune deposits was the only factor associated with development of the composite outcome (hazard ratio: 2.310, 95% confidence interval: 1.031-98.579, P = 0.047).
Glomerular immune deposits were associated with increased risk of a composite outcome in adult MCD patients. The higher rate of non-responders in patients with deposits might be related to the poor outcome. Future study is needed.
关于经活检证实的成人微小病变病(MCD)长期预后不良的危险因素,公开的信息很少。
分析了2003年至2013年期间在一所三级大学医院接受治疗的63例经活检证实的成人原发性MCD患者的数据。评估基线临床和病理因素与肌酐翻倍、终末期肾病或全因死亡率的复合结局之间的关联。
在中位(四分位间距)5.0(2.8 - 5.0)年期间,11.1%(7/63)的患者出现了复合结局。肾小球免疫沉积物的发生率为23.8%(15/63)。有肾小球免疫沉积物的患者尿蛋白肌酐比值显著低于无沉积物的患者(P = 0.033)。有肾小球免疫沉积物的患者无反应者的比例显著高于无沉积物的患者(P = 0.0 ature study is needed.033)。在有沉积物的患者中,26.7%(4/15)出现了复合结局,而在无沉积物的患者中只有6.3%(3/48)出现了复合结局(P = 0.049)。在多变量Cox比例风险回归分析中,肾小球免疫沉积物的存在是与复合结局发生相关的唯一因素(风险比:2.310,95%置信区间:1.031 - 98.579,P = 0.047)。
肾小球免疫沉积物与成人MCD患者复合结局风险增加相关。有沉积物的患者无反应者比例较高可能与预后不良有关。需要进一步研究。